Anavex Life Sciences Corp (AVXL)

[abew4me]

Quote: "I think that this talking point is more political than clinical. It subtly affirms that blarcamesine works differently than the monoclonal antibodies and it also positions Anavex as a less threatening actor."

Yes. Exactly. We must remember that BP owns the mabs...and the mabs have been approved by the FDA. Therefore Dr. Missling has figured out a way to appease BP by emphasizing a combination therapy...and thus, the FDA will be open to approving our drug.

Kudos to Dr. Missling for this strategy!

Masterfully done!